New Autism Spectrum Disorders Study Findings Have Been Reported by Researchers at University of North Carolina Chapel Hill (Fertility Treatment, Female-Factor Infertility, and Autism Spectrum Disorder: Study to Explore Early Development).

The article focuses on research examining the association between fertility treatments, specifically ovulation-inducing medications and assisted reproductive technology (ART), and Autism Spectrum Disorder (ASD). Conducted by researchers at the University of North Carolina Chapel Hill, the study utilized data from the Study to Explore Early Development (SEED) and included a subsample of women with female-factor infertility to minimize confounding factors. The findings indicated no significant association between ovulation-inducing medications and ASD, while a slight increased likelihood of ASD was observed with ART and combined treatments in the overall sample. The researchers suggest that further studies should focus on populations with similar infertility indications to clarify the observed associations. [Extracted from the article]